Copyright Notice
This is a work of the US government and distributed under the terms of the Public Domain
Bookshelf ID: NBK576208
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Leakey JEA, Allaben WT, Dunnick JK, et al. NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet]. Research Triangle Park (NC): National Toxicology Program; 2013 Oct.
NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study): NTP GMM 14 [Internet].
Show detailsThe members of the Peer Review Panel who evaluated the draft NTP Report on 3′-azido-3′-deoxythymidine on February 9, 2012, are listed below. Panel members serve as independent scientists, not as representatives of any institution, company, or governmental agency. In this capacity, panel members have five major responsibilities in reviewing the NTP studies:
- to ascertain that all relevant literature data have been adequately cited and interpreted,
- to determine if the design and conditions of the NTP studies were appropriate,
- to ensure that the Technical Report presents the experimental results and conclusions fully and clearly,
- to judge the significance of the experimental results by scientific criteria, and
- to assess the evaluation of the evidence of carcinogenic activity and other observed toxic responses.
- Stephen M. Roberts, Ph.D., ChairpersonCollege of Veterinary MedicineUniversity of FloridaGainesville, FL
- Jane Alcorn, D.V.M., Ph.D.University of SaskatchewanSaskatchewan, Canada
- Lucy M. Anderson, Ph.D., ConsultantCatonsville, MD
- Hillary M. Carpenter, III, Ph.D.Minnesota Department of HealthSt. Paul, MN
- Russell C. Cattley, V.M.D., Ph.D.College of Veterinary MedicineAuburn UniversityAuburn, AL
- Michael R. Elwell, D.V.M., Ph.D., Primary ReviewerCovance Laboratories, Inc.Chantilly, VA
- Jon C. Mirsalis, Ph.D.SRI InternationalMenlo Park, CA
- Ofelia A. Olivero, Ph.D., Primary ReviewerNational Cancer InstituteBethesda, MD
- Lisa A. Peterson, Ph.D.University of MinnesotaMinneapolis, MN
- Michael V. Pino, D.V.M., Ph.D.SanofiBridgewater, NJ
- Keith A. Soper, Ph.D., Primary ReviewerMerck Research LaboratoriesWest Point, PA
- NATIONAL TOXICOLOGY PROGRAM TECHNICAL REPORTS PEER REVIEW PANEL - NTP Geneticall...NATIONAL TOXICOLOGY PROGRAM TECHNICAL REPORTS PEER REVIEW PANEL - NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study)
- ORGAN WEIGHTS AND ORGAN-WEIGHT-TO-BODY-WEIGHT RATIOS - NTP Genetically Modified ...ORGAN WEIGHTS AND ORGAN-WEIGHT-TO-BODY-WEIGHT RATIOS - NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study)
- CLINICAL PATHOLOGY RESULTS - NTP Genetically Modified Model Report on the Toxico...CLINICAL PATHOLOGY RESULTS - NTP Genetically Modified Model Report on the Toxicology and Carcinogenicity Studies of 3’-Azido-3’-Deoxythymidine (CASRN 30516-87-1) in Genetically Modified C3B6.129F1-Trp53tm1Brd N12 Haploinsufficient Mice (In Utero and Postnatal Gavage Study)
Your browsing activity is empty.
Activity recording is turned off.
See more...